focus -WSS

focus

author：fashion 2025-09-05 09:18:02 - browse：573

WASHINGTON — Grail is aggressively lobbying to get Medicare to pay for its cancer-screening test Galleri — but experts tell STAT that the company has a far more complicated path to that end than the makers of most medicines or medical devices.

Grail’s controversial blood test Galleri screens for multiple cancers. The Food and Drug Administration has not yet approved it, so Medicare hasn’t had to make a decision on whether to cover it or not. Right now, most people pay for it out of pocket. It runs about $950.

In general, Medicare covers FDA-approved medicines and medical devices that help diagnose or treat disease or injury. But there’s a catch for Grail: Medicare doesn’t cover tests that simply screen healthy people, as Galleri does.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum
Next article： Smaller biotechs seek to piggyback on weight loss drug boom

WSS

Parents surprise family after baby discharged from NICU after 170 days

Presidential fundraising highlights so far: Trump brings in more than DeSantis

Rikers Island jail violence not addressed, NYC should be held in contempt: Fed monitor

Nevada Republican Sam Brown launching another Senate bid, teeing up marquee race

Health tech investors get more selective as pandemic boom fades

White House announces new plan to address the growing threat of xylazine in overdose crisis

hotspot

focus

focus

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Swim instructor mom warns parents not to buy blue swimsuits for kids

Moonlake's readout produced a cash windfall. Risks remain

Bank of America ordered to pay more than $100 million for double charging fees, withholding rewards

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Create a giant ice tray with this foil pan hack to keep food cold this summer

Wildfire smoke exposes gaps in outdoor worker protections

Why a market frenzy over new weight loss drugs defies logic

Hepatitis C has a cure — but many Americans still lack access to it

Cassava Sciences’ Alzheimer’s clinical trials should be halted

Wikipedia

Teachers share how revamped forgiveness program helped with their student loans

Wisconsin governor employs partial veto to fund schools for 4 centuries

DeSantis defends odds vs. Trump, despite early poll gap: 'We've worked really hard'

The U.S. needs a new definition of substance use “recovery”

CZI to create biohub to build anti

Medicare wants to send $9 billion to 340B hospitals

focus

hotspot

entertainment

hotspot